Page last updated: 2024-08-23

ursodeoxycholic acid and Myelodysplastic Syndromes

ursodeoxycholic acid has been researched along with Myelodysplastic Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cortes, J; Estey, E; Garcia-Manero, G; Giles, F; Kantarjian, H; Thomas, D	1

Other Studies

1 other study(ies) available for ursodeoxycholic acid and Myelodysplastic Syndromes

Article	Year
Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy. Haematologica, 2002, Volume: 87, Issue:10 Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Drug Interactions; Female; Gemtuzumab; Hepatic Veno-Occlusive Disease; Humans; Immunotoxins; Liver Diseases; Male; Middle Aged; Myelodysplastic Syndromes; Sialic Acid Binding Ig-like Lectin 3; Stem Cell Transplantation; Time Factors; Ursodeoxycholic Acid	2002

Article

Year

Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy.

Haematologica, 2002, Volume: 87, Issue:10

Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Drug Interactions; Female; Gemtuzumab; Hepatic Veno-Occlusive Disease; Humans; Immunotoxins; Liver Diseases; Male; Middle Aged; Myelodysplastic Syndromes; Sialic Acid Binding Ig-like Lectin 3; Stem Cell Transplantation; Time Factors; Ursodeoxycholic Acid

2002